These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23934115)

  • 1. Ultrasound-guided transhepatic radiofrequency ablation of renal tumors: a safe and effective approach.
    Hegg RM; Schmit GD; Kurup AN; Weisbrod AJ; Boorjian SA; Atwell TD
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):508-12. PubMed ID: 23934115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
    Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
    Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
    Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
    Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
    Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
    Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transhepatic approach for percutaneous computed-tomography-guided radiofrequency ablation of renal cell carcinoma.
    Iguchi T; Hiraki T; Gobara H; Mukai T; Hase S; Fujiwara H; Tajiri N; Sakurai J; Mimura H; Saika T; Kumon H; Kanazawa S
    Cardiovasc Intervent Radiol; 2007; 30(4):765-9. PubMed ID: 17508240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
    Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
    Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
    Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
    AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup.
    Varkarakis IM; Allaf ME; Inagaki T; Bhayani SB; Chan DY; Su LM; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2005 Aug; 174(2):456-60; discussion 460. PubMed ID: 16006864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
    Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
    J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
    Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
    Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.